Avalo Therapeutics Inc AVTX Q1 2026 Earnings NarrowerThanExpected Loss Marks Continued Progress for ClinicalStage Biotech Puma Biotechnology PBYI Q1 2026 Earnings EPS Beats Estimates by Wide Margin Shares Rise DSGR Q1 2026 Earnings EPS Beats Estimates Despite Modest Stock Decline FCAP Q1 2026 Earnings Solid EPS of 130 Drives Modest Stock Gain FMBH Q1 2026 Earnings EPS Surpasses Expectations Stock Moves Lower UNP Q1 2026 Earnings EPS Beats Estimates Amid Strong Operational Performance